Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Derek T. Chalmers currently holds 991,405 shares of Cara Therapeutics, Inc. (CARA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Derek T. Chalmers has been a net seller of CARA stock. They have purchased $0 and sold $7.2M worth of shares.
Derek T. Chalmers's most recent insider trade was on Sep 7, 2021, when they sold 20,000 shares at $15.47 per share.
Derek T. Chalmers serves as Executive at Cara Therapeutics, Inc. (CARA). They have executed 58 insider transactions totaling $7.2M over their tenure at the company.
Derek T. Chalmers holds the position of Executive at Cara Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Derek T. Chalmers has shown a selling trading pattern, with $0 in total purchases and $7.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Derek T. Chalmers was on Oct 1, 2018, when they sold $475.8K worth of CARA shares. This transaction involved 20,000 shares at $23.79 per share.
Derek T. Chalmers currently owns 991,405 shares of Cara Therapeutics, Inc. (CARA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Derek T. Chalmers's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Derek T. Chalmers has 58 Form 4 filings on record as an insider at Cara Therapeutics, Inc..
Set alerts for Derek T. Chalmers and 40,000+ other insiders.